 PROJECTED ACCRUAL: A total of 3-24 patients will be accrued for the phase I portion of the study within 1-8 months. A total of 50 patients 32 patients with glioblastoma multiforme and 18 with anaplastic glioma will be accrued for the phase II portion of the study within 8-12 months. 